Sangamo

Business News

Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact

Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact On Monday, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) regained the development and…

Read More »
Back to top button